| Philip R Rizzuto, MD | |
|
120 Dudly St, Suite 301, Providence, RI 02905 | |
| (401) 274-6622 | |
| (401) 490-7051 |
| Full Name | Philip R Rizzuto |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 34 Years |
| Location | 120 Dudly St, Providence, Rhode Island |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710950142 | NPI | - | NPPES |
| 9025630 | Medicaid | RI | |
| 25630 | Other | RI | BLUE SHIELD |
| 3190323 | Other | WELFARE | |
| 401138 | Other | RI | BLUECROSS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | MD08913 (Rhode Island) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Rhode Island Hospital | Providence, RI | Hospital |
| Entity Name | Lifespan Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407116643 PECOS PAC ID: 2567455082 Enrollment ID: O20121029000368 |
News Archive
Researchers are beginning recruitment in a trial to see if changing pregnant women's hygiene habits could reduce the risks of a major cause of childhood disabilities.
Health-conscious consumers are paying closer attention to the numbers and dates stamped on the bottom of their favorite cereals, canned goods, packaged snacks and even fresh produce. But what do all these numbers really mean?
Cancer treatment isn't just a matter of shrinking or removing a tumor. It also involves preserving or improving the patient's quality of life.
An unfortunate side effect of the platinum-chemotherapy drug oxaliplatin is the development of neurotoxicity, which can adversely affect a patient's quality of life; therefore, the benefit of oxaliplatin-based therapy must be balanced with prevention of neuropathies. Currently, there are no therapeutic interventions available to relieve oxaliplatin-associated neurological symptoms, which are thought to be a result of reactive oxygen species-associated damage.
A team of researchers from the University of Maryland School of Pharmacy and the University of Maryland School of Medicine found that current (prolonged) use of serotonin reuptake inhibitors – a major class of antidepressant medications – in children and adolescents was associated with a nearly two-fold increased risk of developing type 2 diabetes when compared to youths who formerly used (but eventually discontinued) those medications.
› Verified 9 days ago
| Entity Name | Philip R Rizzuto Md Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548442338 PECOS PAC ID: 7315171683 Enrollment ID: O20130930000354 |
News Archive
Researchers are beginning recruitment in a trial to see if changing pregnant women's hygiene habits could reduce the risks of a major cause of childhood disabilities.
Health-conscious consumers are paying closer attention to the numbers and dates stamped on the bottom of their favorite cereals, canned goods, packaged snacks and even fresh produce. But what do all these numbers really mean?
Cancer treatment isn't just a matter of shrinking or removing a tumor. It also involves preserving or improving the patient's quality of life.
An unfortunate side effect of the platinum-chemotherapy drug oxaliplatin is the development of neurotoxicity, which can adversely affect a patient's quality of life; therefore, the benefit of oxaliplatin-based therapy must be balanced with prevention of neuropathies. Currently, there are no therapeutic interventions available to relieve oxaliplatin-associated neurological symptoms, which are thought to be a result of reactive oxygen species-associated damage.
A team of researchers from the University of Maryland School of Pharmacy and the University of Maryland School of Medicine found that current (prolonged) use of serotonin reuptake inhibitors – a major class of antidepressant medications – in children and adolescents was associated with a nearly two-fold increased risk of developing type 2 diabetes when compared to youths who formerly used (but eventually discontinued) those medications.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Philip R Rizzuto, MD 120 Dudly St, Suite 301, Providence, RI 02905 Ph: (401) 274-6622 | Philip R Rizzuto, MD 120 Dudly St, Suite 301, Providence, RI 02905 Ph: (401) 274-6622 |
News Archive
Researchers are beginning recruitment in a trial to see if changing pregnant women's hygiene habits could reduce the risks of a major cause of childhood disabilities.
Health-conscious consumers are paying closer attention to the numbers and dates stamped on the bottom of their favorite cereals, canned goods, packaged snacks and even fresh produce. But what do all these numbers really mean?
Cancer treatment isn't just a matter of shrinking or removing a tumor. It also involves preserving or improving the patient's quality of life.
An unfortunate side effect of the platinum-chemotherapy drug oxaliplatin is the development of neurotoxicity, which can adversely affect a patient's quality of life; therefore, the benefit of oxaliplatin-based therapy must be balanced with prevention of neuropathies. Currently, there are no therapeutic interventions available to relieve oxaliplatin-associated neurological symptoms, which are thought to be a result of reactive oxygen species-associated damage.
A team of researchers from the University of Maryland School of Pharmacy and the University of Maryland School of Medicine found that current (prolonged) use of serotonin reuptake inhibitors – a major class of antidepressant medications – in children and adolescents was associated with a nearly two-fold increased risk of developing type 2 diabetes when compared to youths who formerly used (but eventually discontinued) those medications.
› Verified 9 days ago
Marjorie A. Murphy, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: One Hoppin Street, Suite 202, Providence, RI 02903 Phone: 401-831-4592 Fax: 401-831-4643 | |
Michael E Migliori, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1 Hoppin St, Suite 202, Providence, RI 02903 Phone: 401-444-6551 Fax: 401-444-6587 | |
Dr. Noelle Layer Pruzan, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 623 Atwells Ave, Providence, RI 02909 Phone: 401-273-7100 | |
Dr. Harold Arthur Woodcome Jr., MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 101 Plain St Ste 101, Providence, RI 02903 Phone: 401-274-5844 Fax: 401-274-9462 | |
Joseph Francis Ducharme, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 78 Baker Street, Providence, RI 02905 Phone: 401-831-4592 Fax: 401-831-4643 | |
John P Donahue, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 150 E Manning St, Providence, RI 02906 Phone: 401-272-2020 Fax: 401-421-5979 | |
King Wai To, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: One Hoppin Street, Suite 202, Providence, RI 02903 Phone: 401-831-4592 Fax: 401-831-4643 |